Maxime Dougados

Summary

Country: France

Publications

  1. ncbi Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort
    Ho Yin Chung
    Correspondence to Professor Maxime Dougados, Rheumatology B Department, Cochin Hospital, Paris 75014, France
    Ann Rheum Dis 71:809-16. 2012
  2. ncbi Onset of action of etanercept in rheumatoid arthritis based on patient-reported outcomes
    Maxime Dougados
    Paris Descartes University UPRES EA 4058 APHP, Cochin Hospital, Rheumatology B Dpt, 75014 Paris, France
    Clin Exp Rheumatol 30:266-8. 2012
  3. ncbi Profile and course of early rheumatoid arthritis in Morocco: a two-year follow-up study
    Karima Benbouazza
    Rheumatology Department, Mohamed Vth University Souissi, Rabat, Morocco
    BMC Musculoskelet Disord 12:266. 2011
  4. ncbi Status versus changes, onset of action, and sustainability--how do we define and present these concepts in clinical trial reports in rheumatology?
    Maxime Dougados
    Rheumatology B Department, Hopital Cochin, 27 rue du Faubourg Saint Jacques, Paris, France
    Bull NYU Hosp Jt Dis 69:111-5. 2011
  5. ncbi ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis
    Maxime Dougados
    Rheumatology B Department, Paris Descartes University, Cochin Hospital, Paris 75014, France
    Ann Rheum Dis 70:249-51. 2011
  6. ncbi Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: results from a prospective multicentre study of rheumatoid arthritis
    Maxime Dougados
    Medicine Faculty, Rheumatology B Department, Descartes University UPRES EA 4058 APHP, Cochin Hospital, 27 rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Rheum Dis 69:828-33. 2010
  7. ncbi Symptomatic slow-acting drugs for osteoarthritis: what are the facts?
    Maxime Dougados
    Rheumatology Department, Cochin Teaching Hospital, School of Medicine, Paris Descartes University, Assistance Publique Hopitaux de Paris, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Joint Bone Spine 73:606-9. 2006
  8. ncbi Spondyloarthritis
    Maxime Dougados
    Paris Descartes University, Medicine Faculty, UPRES EA 4058, AP HP, Cochin Hospital, Department of Rheumatology B, Paris, France
    Lancet 377:2127-37. 2011
  9. ncbi Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis
    Jeremie Sellam
    Hopital Bicetre, AP HP, INSERM U1012, and Université Paris Sud 11, Le Kremlin Bicetre, France
    Arthritis Rheum 63:3692-701. 2011
  10. ncbi Structural evaluation in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion
    Laure Gossec
    Rheumatology Department, Cochin Teaching Hospital, Paris, France
    Joint Bone Spine 72:229-34. 2005

Detail Information

Publications127 found, 100 shown here

  1. ncbi Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort
    Ho Yin Chung
    Correspondence to Professor Maxime Dougados, Rheumatology B Department, Cochin Hospital, Paris 75014, France
    Ann Rheum Dis 71:809-16. 2012
    ..To investigate the association of smoking with various clinical, functional and imaging outcomes in patients with early axial spondyloarthritis (SpA)...
  2. ncbi Onset of action of etanercept in rheumatoid arthritis based on patient-reported outcomes
    Maxime Dougados
    Paris Descartes University UPRES EA 4058 APHP, Cochin Hospital, Rheumatology B Dpt, 75014 Paris, France
    Clin Exp Rheumatol 30:266-8. 2012
    ..The efficacy of TNF blockers is usually evaluated after 2 to 4 weeks of therapy. EULAR-RAID is a valid patient-reported outcome composite index...
  3. ncbi Profile and course of early rheumatoid arthritis in Morocco: a two-year follow-up study
    Karima Benbouazza
    Rheumatology Department, Mohamed Vth University Souissi, Rabat, Morocco
    BMC Musculoskelet Disord 12:266. 2011
    ..This study aimed to establish the profile and the evolution of an early Rheumatoid arthritis (RA) cohort in the Moroccan population and also to search possible predictor factors of structural progression...
  4. ncbi Status versus changes, onset of action, and sustainability--how do we define and present these concepts in clinical trial reports in rheumatology?
    Maxime Dougados
    Rheumatology B Department, Hopital Cochin, 27 rue du Faubourg Saint Jacques, Paris, France
    Bull NYU Hosp Jt Dis 69:111-5. 2011
    ....
  5. ncbi ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis
    Maxime Dougados
    Rheumatology B Department, Paris Descartes University, Cochin Hospital, Paris 75014, France
    Ann Rheum Dis 70:249-51. 2011
    ..This initiative should facilitate the conduct and analysis of clinical studies/trials...
  6. ncbi Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: results from a prospective multicentre study of rheumatoid arthritis
    Maxime Dougados
    Medicine Faculty, Rheumatology B Department, Descartes University UPRES EA 4058 APHP, Cochin Hospital, 27 rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Rheum Dis 69:828-33. 2010
    ..To evaluate different global ultrasonographic (US) synovitis scoring systems as potential outcome measures of rheumatoid arthritis (RA) according to the Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) filter...
  7. ncbi Symptomatic slow-acting drugs for osteoarthritis: what are the facts?
    Maxime Dougados
    Rheumatology Department, Cochin Teaching Hospital, School of Medicine, Paris Descartes University, Assistance Publique Hopitaux de Paris, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Joint Bone Spine 73:606-9. 2006
    ..In addition, the characteristics of the patients who are most likely to benefit from SySADOA need to be identified...
  8. ncbi Spondyloarthritis
    Maxime Dougados
    Paris Descartes University, Medicine Faculty, UPRES EA 4058, AP HP, Cochin Hospital, Department of Rheumatology B, Paris, France
    Lancet 377:2127-37. 2011
    ....
  9. ncbi Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis
    Jeremie Sellam
    Hopital Bicetre, AP HP, INSERM U1012, and Université Paris Sud 11, Le Kremlin Bicetre, France
    Arthritis Rheum 63:3692-701. 2011
    ..To examine blood B cell subsets in patients with rheumatoid arthritis (RA) prior to B cell depletion therapy and to assess their potential as predictors of clinical response to rituximab (RTX)...
  10. ncbi Structural evaluation in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion
    Laure Gossec
    Rheumatology Department, Cochin Teaching Hospital, Paris, France
    Joint Bone Spine 72:229-34. 2005
    ..They should help to improve practice uniformity and, ultimately, to improve the management of RA...
  11. ncbi Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion
    Laure Gossec
    Service de Rhumatologie B, CHU de Cochin, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France
    Joint Bone Spine 73:396-402. 2006
    ..CONCLUSION: These recommendations should help to improve practice uniformity and, ultimately, to improve the management of RA...
  12. ncbi A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial
    Maxime Dougados
    Paris Descartes University, and APHP, Rheumatology B Department, Cochin Hospital, Paris, France
    Ann Rheum Dis 69:1430-5. 2010
    ..The objective of this study was to investigate the efficacy of etanercept in refractory heel enthesitis related to SpA...
  13. ncbi Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion
    Stephan Pavy
    Service de Rhumatologie A, CHU Cochin, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France
    Joint Bone Spine 73:388-95. 2006
    ..CONCLUSION: Recommendations about methotrexate therapy for RA were developed. These recommendations should help to improve practice uniformity and, ultimately, to improve the management of RA...
  14. ncbi The influence of the definition of patient global assessment in assessment of disease activity according to the Disease Activity Score (DAS28) in rheumatoid arthritis
    Maxime Dougados
    Department of Rheumatology B, Cochin Hospital, Paris Pfizer SAS France, Paris France
    J Rheumatol 38:2326-8. 2011
    ..We studied the influence of the use of 3 different techniques of PGA on the assessment of disease activity...
  15. ncbi Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment
    Maxime Breban
    Hopital Ambroise Pare, Assistance Publique Hopitaux de Paris, Boulogne Billancourt, France
    Arthritis Rheum 58:88-97. 2008
    ..This study was undertaken to compare the efficacy of continuous treatment with infliximab with that of a treatment regimen adapted to symptom recurrence. Methotrexate (MTX) in combination with infliximab was also tested...
  16. ncbi Self-reported prevalence of psoriasis and evaluation of the impact on the natural history of hip osteoarthritis: results of a 10 years follow-up study of 507 patients (ECHODIAH study)
    Umut Kalyoncu
    Paris Descartes University, Medicine Faculty, UPRES EA 4058, APHP, Rheumatology B Department, Cochin Hospital, Paris, France
    Joint Bone Spine 76:389-93. 2009
    ..The objective of the present study was to assess the frequency of self-reported psoriasis in a hip osteoarthritis (OA) cohort, and a secondary objective was to assess the course of hip OA with psoriasis...
  17. ncbi Retention rates of tumor necrosis factor blockers in daily practice in 770 rheumatic patients
    Muriel Duclos
    Rene Descartes University, Faculty of Medicine, Paris, France
    J Rheumatol 33:2433-8. 2006
    ..Moreover, results suggest greater benefit in SpA. The role of concomitant DMARD remains to be confirmed...
  18. ncbi Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study
    Natacha Courvoisier
    Service de Rhumatologie, Hopital Saint Antoine, 184 rue du Faubourg Saint Antoine, Paris, 75012, France
    Arthritis Res Ther 10:R106. 2008
    ..The objectives of this study were to determine the predictive factors of long-term radiographic outcome of rheumatoid arthritis (RA) and to describe the relationship between joint damage and disability over the course of the disease...
  19. ncbi OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugs
    Maxime Dougados
    Paris Descartes University, Medicine Faculty, UPRES EA 4058, AP HP, Cochin Hospital, Rheumatology B Department, Paris, France
    J Rheumatol 36:2097-9. 2009
    ..We propose a composite index including structural and symptomatic variables of osteoarthritis (OA) as criteria for being considered a candidate for total joint replacement as an endpoint in clinical trials evaluating potential DMOAD...
  20. ncbi Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment
    Karine Briot
    Paris Descartes University, Medicine Faculty, Cochin Hospital, Paris, France
    J Rheumatol 35:855-61. 2008
    ..To determine the changes in body weight, body composition, and bone density in patients with spondyloarthropathy (SpA) receiving anti-tumor necrosis factor-alpha (TNF-alpha) treatment...
  21. ncbi Rituximab therapy in rheumatoid arthritis in daily practice
    Noémie Assous
    Department of Rheumatology A and Rheumatology B, Paris Descartes University, Medical Faculty, Cochin Hospital, AP HP, Paris, France
    J Rheumatol 35:31-4. 2008
    ..Our aim was to assess in routine care the effects of rituximab in patients with RA who had experienced an inadequate response to anti-tumor necrosis factor-alpha (TNF-alpha) agents or had a contraindication to these drugs...
  22. ncbi Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort
    Carine Salliot
    Paris Descartes University, Medicine Faculty UPRES EA 4058 APHP, Hopital Cochin, Service de Rhumatologie B, rue du Faubourg Saint Jacques, Paris, France
    Ann Rheum Dis 69:1683-6. 2010
    ....
  23. ncbi Feeling good rather than feeling better matters more to patients
    Florence Tubach
    Assistance Publique Hopitaux de Paris, Hopital Bichat, INSERM U738, Universite Paris 7 Denis Diderot, Paris, France
    Arthritis Rheum 55:526-30. 2006
    ....
  24. ncbi Prevalence and clinical characteristics of dactylitis in spondylarthritis: a descriptive analysis of 275 patients
    Judith Payet
    Paris Descartes University, Medicine Faculty, APHP, Rheumatology B Department, Cochin Hospital, Paris, France
    Clin Exp Rheumatol 30:191-6. 2012
    ..Our objective was to assess the prevalence of dactylitis among a cohort of patients with spondylarthritis in a tertiary care centre and to describe the clinical characteristics of dactylitis...
  25. ncbi Performance of the assessment in spondyloarthritis international society classification for axial and peripheral spondyloarthritis in an established clinical cohort: comparison with criteria sets of amor and the European spondylarthropathy study group
    Peter P Cheung
    Rheumatology B Department, Hopital Cochin, 27 rue du Faubourg Saint Jacques, 75014, Paris, France
    J Rheumatol 39:816-21. 2012
    ..To evaluate the performance of the Assessment in Spondyloarthritis International Society (ASAS) criteria (axial or peripheral) against the Amor and European Spondylarthropathy Study Group criteria in established spondyloarthritis (SpA)...
  26. ncbi Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis
    Olivier Meyer
    Rheumatology Unit, Assistance Publique Hopitaux de Paris, Bichat University Hospital, 75018 Paris, France
    Arthritis Res Ther 8:R40. 2006
    ..In conclusion, serially determined anti-CCP2 antibodies during the first three years of follow-up performs better than baseline determination for predicting radiographic progression in patients with early RA...
  27. ncbi Influence of patient education on exercise compliance in rheumatoid arthritis: a prospective 12-month randomized controlled trial
    Anne Mayoux-Benhamou
    Department of Rehabilitation, Cochin Hospital, 27 rue du Faubourg Saint Jacques, 75679 Paris Cedex 14, France
    J Rheumatol 35:216-23. 2008
    ..To determine the effect of education on the exercise habits of patients with rheumatoid arthritis (RA) after 6 and 12 months...
  28. ncbi Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis
    Florence Tubach
    Assistance Publique Hopitaux de Paris, Bichat Hospital, University Paris VII, INSERM U738, Paris, France
    Arthritis Rheum 55:960-3. 2006
    ..Our goal was to determine the PASS in main outcome criteria when assessing patients with ankylosing spondylitis (AS) and to evaluate whether the PASS is stable over time...
  29. ncbi Reliability of patient self-evaluation of swollen and tender joints in rheumatoid arthritis: A comparison study with ultrasonography, physician, and nurse assessments
    Peter P Cheung
    Paris Descartes University, UPRES EA, Cochin Hospital, France
    Arthritis Care Res (Hoboken) 62:1112-9. 2010
    ....
  30. ncbi B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six-month, national, multicenter, open-label study
    Jeremie Sellam
    Hopital Bicetre, Assistance Publique Hopitaux de Paris, INSERM U1012, and Université Paris Sud 11, Le Kremlin Bicetre, France
    Arthritis Rheum 63:933-8. 2011
    ..To examine whether serum B cell markers can predict response to rituximab, a B cell-depleting monoclonal antibody, in patients with refractory rheumatoid arthritis (RA)...
  31. ncbi PTPN22 R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis: results from the ESPOIR cohort
    Carine Salliot
    Rheumatology B Department, Cochin Hospital, Paris Descartes University, Medicine Faculty UPRES EA 4058 APHP, France
    Rheumatology (Oxford) 50:1802-8. 2011
    ..To investigate genotype-phenotype correlation and gene-environment interaction between PTPN22 R620W environmental factors such as tobacco/hormonal treatments in an inception cohort of RA patients...
  32. ncbi OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group
    Laure Gossec
    Paris Descartes University, Medicine Faculty, Paris, France
    J Rheumatol 38:1765-9. 2011
    ....
  33. ncbi The DESIR cohort: A 10-year follow-up of early inflammatory back pain in France: Study design and baseline characteristics of the 708 recruited patients
    Maxime Dougados
    Paris Descartes University, Medicine Faculty, UPRES EA 4058, AP HP, Cochin Hospital, Rheumatology B Department, Paris 14, France
    Joint Bone Spine 78:598-603. 2011
    ....
  34. ncbi Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein
    Mathilde Benhamou
    Rheumatology Department, Pitie Salpetriere Hospital, Paris VI University, France
    Rheumatology (Oxford) 49:536-41. 2010
    ..To evaluate the clinical relevance of CRP in AS and investigate the treatment effect of NSAIDs/coxibs on CRP...
  35. ncbi Validation of a short form of the Western Ontario and McMaster Universities Osteoarthritis Index function subscale in hip and knee osteoarthritis
    Gabriel Baron
    AP HP, Hopital Bichat, Département d Eidémiologie, Biostatistique et Recherche Clinique, INSERM, U738, Paris, France
    Arthritis Rheum 57:633-8. 2007
    ..The goal of the present study was to validate this short form...
  36. ncbi Reproducibility and sensitivity to change of four scoring methods for the radiological assessment of osteoarthritis of the hand
    Emmanuel Maheu
    Rheumatology Department, Hopital Saint Antoine, and Université Diderot, Paris VII, France
    Ann Rheum Dis 66:464-9. 2007
    ..Osteoarthritis (OA) of the hand could be a relevant model to study the progression of OA in structure-modification trials. Various methods are proposed to assess hand OA and its progression radiologically...
  37. ncbi Impact of ultrasound imaging on local corticosteroid injections of symptomatic ankle, hind-, and mid-foot in chronic inflammatory diseases
    Xavier Ayral
    Cochin Hospital, , Paris, France
    Arthritis Rheum 53:284-92. 2005
    ..0170). CONCLUSION: US frequently led the physician to change his diagnosis of inflammatory lesions in painful foot, and consequently his planning of CS injections. Moreover, US could improve the response to local treatment...
  38. ncbi Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders
    Florence Tubach
    Département d Epidémiologie, Biostatistique et Recherche Clinique, Hopital Bichat, Paris, France
    J Rheumatol 34:1188-93. 2007
    ..The purpose of this SIG at OMERACT 8 was to inform participants of the MCII and PASS concepts and to agree on MCII and PASS values for pain, patient global assessment, and functional impairment...
  39. ncbi C-reactive protein predicts tumor necrosis factor-alpha blocker retention rate in axial ankylosing spondylitis
    Mathieu Luc
    Department of Rheumatology B, Paris 5 Medicine Faculty, Cochin Hospital, APHP, Paris, France
    J Rheumatol 34:2078-81. 2007
    ..We assessed the retention rate of TNF blockers in patients with axial AS, according to baseline CRP and other potentially predictive measures...
  40. ncbi Role and modalities of information and education in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion
    Bruno Fautrel
    Service de Rhumatologie, , Paris, France
    Joint Bone Spine 72:163-70. 2005
    ..7% to 100%. CONCLUSION: Recommendations about educating and informing patients with RA in everyday practice were developed. They should increase practice uniformity and ultimately optimize the management of patients with RA...
  41. ncbi Influence of the experience of the reader on reliability of joint space width measurement. A cross-sectional multiple reading study in hip osteoarthritis
    Paul Ornetti
    Department of Rheumatology, Dijon University Hospital, Medicine Faculty, Burgundy University, 3, rue du Faubourg Raines, 21000 Dijon, France
    Joint Bone Spine 78:499-505. 2011
    ..The objectives were to evaluate improvement in reliability of joint space width (JSW) measurements, according to the previous experience of the readers in hip osteoarthritis (OA)...
  42. ncbi Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases
    Guillaume Geri
    Paris Descartes University, Medicine Faculty, Assistance Publique Hopitaux de Paris, Rheumatology B Department, Cochin Hospital, Paris France
    BMC Infect Dis 11:304. 2011
    ..Data are lacking on the risk of lower respiratory tract infections in patients treated with biologic agents...
  43. ncbi Usefulness of routine electrocardiography for heart disease screening in patients with spondyloarthropathy or rheumatoid arthritis
    Tiphaine Miquel Goulenok
    Services de Rhumatologie A, Hopital Cochin, AP HP, Universite Paris Descartes, 27, rue du faubourg 75679 Paris cedex 14, France
    Joint Bone Spine 77:146-50. 2010
    ..To assess the usefulness of routine electrocardiography for heart disease screening in patients with spondyloarthropathy (SpA) or rheumatoid arthritis (RA)...
  44. ncbi Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy
    Karine Briot
    Faculte de Medecine, Universite Paris Descartes, UPRES EA 4058, Hopital Cochin, Paris, France
    J Rheumatol 35:310-4. 2008
    ..We describe the effects of etanercept on biochemical markers of type II collagen synthesis and degradation in patients with SpA followed for 2 years...
  45. ncbi Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: data from a randomized controlled trial
    Maxime Dougados
    Hôpital Cochin and University of Paris, Paris, France
    Arthritis Rheum 59:553-60. 2008
    ..To evaluate the feasibility/acceptability, reliability, external validity, and discriminant capacity of the Patient Acceptable Symptom State (PASS) concept in patients with active ankylosing spondylitis (AS)...
  46. ncbi Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: results from a randomized control study
    Roman Krzysiek
    Inserm Unité 764, Universite Paris Sud 11, and Hôpital Antoine Béclère, Assistance Publique Hopitaux de Paris, Clamart, France
    Arthritis Rheum 61:569-76. 2009
    ..This study compared the circulating infliximab concentration and the presence of clinical symptoms in patients continuously treated with infliximab or after treatment interruption...
  47. ncbi Evaluation of the patient acceptable symptom state in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis
    Maxime Dougados
    Department of Rheumatology, Hopital Cochin, 27 rue du Faubourg Saint Jacques, 75014 Paris, France
    Arthritis Res Ther 9:R11. 2007
    ..Trial registration numbers: NCT00366938 and NCT00367315...
  48. ncbi Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor ?-blockers: a case-control study
    Melanie Gilson
    Rheumatology B Department, Cochin Hospital, Paris 75014, France
    Arthritis Res Ther 12:R145. 2010
    ....
  49. ncbi Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments
    Natacha Thelier
    Department of Rheumatology A, Paris Descartes University, Paris, France
    J Rheumatol 35:1622-8. 2008
    ..To analyze the pattern of osteoarticular lesions in patients with sarcoidosis hospitalized in 4 rheumatology departments...
  50. ncbi Intraarticular glucocorticoid injections in rapidly destructive hip osteoarthritis
    Caroline Villoutreix
    Rheumatology B Department, Cochin Teaching Hospital, Assistance Publique des Hopitaux de Paris, René Descartes Paris V University, France
    Joint Bone Spine 73:66-71. 2006
    ....
  51. ncbi Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature
    Sebastien Ottaviani
    Paris Descartes University, Medicine Faculty, APHP, Rheumatology B Department, Cochin Hospital, France
    Semin Arthritis Rheum 40:539-46. 2011
    ..Pigmented villonodular synovitis (PVNS) is a rare but disabling disease. The objective was to describe the clinical presentation and outcomes of PVNS according to its localization...
  52. ncbi Switching between tumour necrosis factor blockers in spondyloarthritis: a retrospective monocentre study of 222 patients
    Sabrina Dadoun
    Paris Descartes University, Paris, France
    Clin Exp Rheumatol 29:1010-3. 2011
    ..To assess the frequency and effectiveness of switching TNF blockers in spondyloarthritis, and the predisposing factors of this effectiveness...
  53. ncbi Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers: example of etanercept in advanced ankylosing spondylitis
    Maxime Dougados
    Paris Descartes University, UPRES EA 4058, AP HP, Cochin Hospital, Paris 14, France
    Arthritis Care Res (Hoboken) 64:290-4. 2012
    ..To evaluate the interest of the Assessment of SpondyloArthritis international Society (ASAS) nonsteroidal antiinflammatory drug (NSAID) score as a quality indicator and a potential outcome measure in clinical studies...
  54. ncbi Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review
    Laure Gossec
    AP HP, Rheumatology B Department, Cochin Hospital, 27 rue du Faubourg St Jacques, Paris 5 University, Paris, France
    Am J Med Sci 334:248-54. 2007
    ....
  55. ncbi Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues
    Florence Tubach
    , Biostatistique et Recherche Clinique, Groupe Hospitalier Bichat-Claude Bernard (AP-HP, INSERM U738, , Paris, France
    J Rheumatol 32:2025-9. 2005
    ..Threshold values for the MCID and LDAS should be determined according to data-driven and experts' opinions and approaches...
  56. ncbi OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis
    Laure Gossec
    Medicine Faculty, Paris 5 René Descartes University AP HP, Cochin Hospital, Department of Rheumatology B, Paris, France
    J Rheumatol 34:1432-5. 2007
    ..quot;..
  57. ncbi Reproducibility and sensitivity to change of various methods to measure joint space width in osteoarthritis of the hip: a double reading of three different radiographic views taken with a three-year interval
    Emmanuel Maheu
    Service de Rhumatologie, Hopital Saint Antoine, Paris, France
    Arthritis Res Ther 7:R1375-85. 2005
    ..6 or greater for assessing JSN over three years. Selecting a single reader was the most accurate method, with 0.3 mm precision. Using this cutoff, 50% of patients were classified as 'progressors'...
  58. ncbi Antisynthetases syndrome associated with right heart failure
    Latifa Tahiri
    Rheumatology Service, Cochin Hospital, Paris Descartes University, AP HP, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Joint Bone Spine 76:715-7. 2009
    ..Treatment with corticosteroids rapidly improved both symptoms and biological abnormalities...
  59. ncbi B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study
    Jeremie Sellam
    Hopital Bicetre, Assistance Publique Hopitaux de Paris, Le Kremlin Bicetre, France
    Arthritis Rheum 63:933-8. 2011
    ..To examine whether serum B cell markers can predict response to rituximab, a B cell-depleting monoclonal antibody, in patients with refractory rheumatoid arthritis (RA)...
  60. ncbi Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry
    Benjamin Terrier
    Bicetre Hospital, Assistance Publique Hopitaux de Paris, and Paris 11 University, Le Kremlin Bicetre, France
    Arthritis Rheum 62:2458-66. 2010
    ..However, in 2 recent randomized controlled trials (RCTs) of RTX, the primary end points were not met. We undertook this study to evaluate the safety and efficacy of RTX in off-trial patients with SLE seen in regular clinical practice...
  61. ncbi Relative clinical influence of clinical, laboratory, and radiological investigations in early arthritis on the diagnosis of rheumatoid arthritis. Data from the French Early Arthritis Cohort ESPOIR
    Laure Gossec
    Faculty of Medicine, Paris Descartes University, UPRES EA 4058, APHP, Department of Rheumatology B, Cochin Hospital, Paris, France
    J Rheumatol 37:2486-92. 2010
    ..To evaluate the relative level of influence of usual investigations in early arthritis on the diagnosis of rheumatoid arthritis (RA)...
  62. ncbi The methods for handling missing data in clinical trials influence sample size requirements
    Guy-Robert Auleley
    , , , AP-HP, Paris, France
    J Clin Epidemiol 57:447-53. 2004
    ..CONCLUSIONS: These results can help investigators plan clinical trials to select the primary outcome and a priori specify the way missing data will be handled...
  63. ncbi Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatment
    Marie Gaëlle Bray
    Paris Descartes University, Medicine Faculty, UPRES EA 4058, 75651 Paris, France
    Joint Bone Spine 77:135-41. 2010
    ..However, its toxicity is unknown in this context and is a subject of debate...
  64. ncbi HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis
    Ho Yin Chung
    Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
    Ann Rheum Dis 70:1930-6. 2011
    ..To clarify the influence of human leucocyte antigen B27 (HLA-B27) status on the phenotype of early axial spondyloarthritis (SpA)...
  65. ncbi Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial
    Janine Sophie Giraudet-Le Quintrec
    AP HP, Hopital Cochin, Universite Rene Descartes, Faculte de Medecine, Paris, France
    J Rheumatol 34:1684-91. 2007
    ..To evaluate the effect on health and functional status of an 8-week group-education program for rheumatoid arthritis (RA) in addition to usual medical care...
  66. ncbi Practice patterns in outpatient rheumatology: a pilot evaluation of medical file content
    Jacques Fechtenbaum
    Rheumatology Department B, Cochin Teaching Hospital, AP HP, and René Descartes Paris V University, Paris, France
    Joint Bone Spine 74:171-4. 2007
    ..Subsequently, one of the RHEVER members investigated whether these recommendations were followed by RHEVER participants at a teaching hospital...
  67. ncbi Leflunomide in clinical practice
    Patricia Pinto
    Rene Descartes University, Medicine Faculty, France
    Acta Reumatol Port 31:215-24. 2006
    ..This article reviews the place of LEF in clinical practice and outlines its potential applications beyond the officially recognized indication: rheumatoid arthritis (RA)...
  68. ncbi Do intra-articular therapies work and who will benefit most?
    Laure Gossec
    Service de Rhumatologie B, Hopital Cochin, Rene Descartes University, 27 rue du Faubourg Saint Jacques, 75014 Paris, France
    Best Pract Res Clin Rheumatol 20:131-44. 2006
    ..Some data--mainly from animal studies--suggest a possible long-term chondroprotective effect of hyaluronan. This treatment seems more efficacious in non-radiologically severe osteoarthritis with no or mild effusion...
  69. ncbi The use of glucosamine therapy in osteoarthritis
    Djamila Zerkak
    Rheumatology B Department, Rene Descartes University, AP HP Cochin Hospital, 27 rue du Faubourg Saint Jacques, Paris 75014, France
    Curr Pain Headache Rep 8:507-11. 2004
    ..An ongoing long-term clinical trial in the US will possibly permit to investigate the clinical relevance of these results and give appropriate recommendations...
  70. ncbi Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry
    Marion Couderc
    Rheumatology Department, CHU, Clermont Ferrand, France
    Rheumatology (Oxford) 50:2283-9. 2011
    ..Conclusions. RTX was well tolerated and had some beneficial effects on patients with IIM, the main limitation of this study resulted in a lack of manual muscle testing...
  71. ncbi Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis
    Bruno Fautrel
    Pierre and Marie Curie University Paris VI, UFR de Medecine, France
    Joint Bone Spine 74:627-37. 2007
    ..To update French Society for Rheumatology guidelines regarding the use of TNFalpha antagonists for treating patients with rheumatoid arthritis (RA)...
  72. ncbi Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy
    Jacques-Eric Gottenberg
    , Paris, France
    Arthritis Rheum 48:2019-24. 2003
    ....
  73. ncbi Why and how to use NSAIDs in osteoarthritis
    Maxime Dougados
    Medicine Faculty, Rene Descartes University, and Rheumatology B Department, AP HP Cochin Hospital, Paris, France
    J Cardiovasc Pharmacol 47:S49-54. 2006
    ....
  74. ncbi Recommendations of the French Society for Rheumatology. TNFalpha antagonist therapy in rheumatoid arthritis
    Bruno Fautrel
    Service de Rhumatologie, Groupe Hospitalier Pitie Salpetriere, UFR de Medecine, Universite Pierre et Marie Curie Paris VI, 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Joint Bone Spine 73:433-41. 2006
    ..To develop recommendations for TNFalpha-antagonist therapy in patients with rheumatoid arthritis (RA) seen in everyday practice, under the aegis of the French Society for Rheumatology...
  75. ncbi Evaluation of disease activity assessments in patients with rheumatoid arthritis and an inadequate response to anti-TNF therapy: analyses of abatacept clinical trial data
    M Dougados
    Rene Descartes University, Medicine Faculty, Hospital Cochin, Rheumatology B Department, Paris, France
    Clin Exp Rheumatol 28:258-60. 2010
    ....
  76. ncbi Significant linkage to spondyloarthropathy on 9q31-34
    Corinne Miceli-Richard
    Laboratoire de Génétique des Maladies Inflammatoires de l Intestin et Fondation Jean Dausset CEPH, Paris, France
    Hum Mol Genet 13:1641-8. 2004
    ..87, LOD=5.15, P=0.00002). This result provides evidence for the presence of a non-MHC susceptibility locus for SpA mapping to 9q31-34...
  77. ncbi Pharmacological management of early rheumatoid arthritis--does combination therapy improve outcomes?
    Maxime Dougados
    Hĵpital Cochin, Department of Rheumatology, Paris, France
    J Rheumatol Suppl 66:20-6. 2002
    ..Collectively, these data are beginning to shed light on how to best treat early RA, suggesting that DMARD work best when given very early...
  78. ncbi Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria
    Thao Pham
    , AP-HP, Rheumatology B Department, Cochin Hospital, Paris, France
    J Rheumatol 30:1648-54. 2003
    ..The conclusions of the task force were presented and discussed during the OMERACT 6 conference, where a simplified set of responder criteria (OMERACT-OARSI set of criteria) was proposed...
  79. ncbi Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study
    Roula Said-Nahal
    Cochin Hospital, INSERM, CNRS, , AP-HP, Paris, France
    Arthritis Rheum 48:523-33. 2003
    ..The presence of entheseal involvement was independent of SpA subtype, but its degree of severity appeared to be greater in peripheral forms. US could be very useful for both the diagnosis and the assessment of SpA activity...
  80. ncbi Selecting criteria for monitoring patients with rheumatoid arthritis
    Martin Soubrier
    Service de Rhumatologie, Rheumatology Department, G Montpied Teaching Hospital, Place Henri Dunant, B P 69, 63003 Clermont Ferrand, France
    Joint Bone Spine 72:129-34. 2005
    ..A standardized follow-up protocol is suggested as a means of achieving greater uniformity in clinical practice...
  81. ncbi Comparison of a computer based method and the classical manual method for radiographic joint space width assessment in hip osteoarthritis
    Jean Francis Maillefert
    , Institute of Rheumatology, Paris, France
    J Rheumatol 29:2592-6. 2002
    ..CONCLUSION: These results suggest that both techniques are reliable and sensitive enough to detect changes in a relevant percentage of patients with hip OA after a 3 year followup...
  82. ncbi Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitis
    Guy-Robert Auleley
    , , Paris, France
    Arthritis Rheum 47:582-7. 2002
    ..Evaluation of the SDD of the symptomatic outcome or process variables is a starting point to determine the minimum clinically important difference, permitting the presentation of results of clinical studies on an individual basis...
  83. ncbi Spondyloarthropathy for practicing rheumatologists: diagnosis, indication for disease-controlling antirheumatic therapy, and evaluation of the response
    Corinne Miceli-Richard
    Department of Rheumatology, , Cochin Hospital, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France
    Rheum Dis Clin North Am 29:449-62. 2003
    ....
  84. ncbi Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis
    Valerie Devauchelle
    Institut Cochin, Departement d Immunologie, 27 rue du Faubourg Saint Jacques, 75674 Paris Cedex 14, France
    J Immunol 177:6471-9. 2006
    ..We propose that in RA joints, high levels of extracellular CLU and low expression of intracellular CLU may enhance NF-kappaB activation and survival of the synoviocytes...
  85. ncbi Leflunomide for the treatment of rheumatoid arthritis
    Corinne Miceli-Richard
    Cochin Hospital, AP-HP, , Paris, France
    Expert Opin Pharmacother 4:987-97. 2003
    ..Further trials are now required to confirm efficacy and safety of this drug in combination with other agents...
  86. ncbi Chondrocalcinosis secondary to hypomagnesemia in Gitelman's syndrome
    Hang Korng Ea
    Rheumatology Department, Rene Descartes University, France
    J Rheumatol 32:1840-2. 2005
    ..Additionally, the association between GS (NCCT inactivation) and high bone mineral density provides a new insight into the possible role of thiazides in osteoporosis management...
  87. ncbi Monitoring osteoarthritis progression and therapy
    Maxime Dougados
    Université René Descarte and Hôpital Cochin, Paris, France
    Osteoarthritis Cartilage 12:S55-60. 2004
    ..The requirement for total hip arthroplasty has been evaluated as a composite outcome measure for trials of hip OA and found to be valid, simple, and clinically pertinent...
  88. ncbi Flory syndrome or lymphomonocytic/low-neutrophil oligoarthritis: a diagnosis or a prognosis?
    Bernard Amor
    Rheumatology Department, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Joint Bone Spine 70:122-7. 2003
    ..To individualize a new clinical entity of chronic arthritis and/or a factor indicating good prognosis of chronic arthritis...
  89. ncbi [Rheumatology, prospects of development]
    Maxime Dougados
    Service de Rhumatologie B, , 27, rue du Faubourg Saint-Jacques, 75014 Paris
    Presse Med 33:Sp111-4. 2004
  90. ncbi How can one develop disease-modifying drugs in osteoarthritis?
    Maxime Dougados
    Rene Descartes University, Cochin Hospital, 27 rue du Faubourg, Saint Jacques, 75014 Paris, France
    Curr Rheumatol Rep 7:22-8. 2005
    ....
  91. ncbi A composite index for total hip arthroplasty in patients with hip osteoarthritis
    Jean Francis Maillefert
    Institute of Rheumatology, , Cochin Hospital, Paris, France
    J Rheumatol 29:347-52. 2002
    ..On the other hand, the high negative predictive values suggest that these composite measures should be used by clinicians to determine which patients should not be referred to THA...
  92. ncbi Ankylosing spondylitis: how should the disease be assessed?
    Maxime Dougados
    , Cochin Hospital, Paris, France
    Best Pract Res Clin Rheumatol 16:605-18. 2002
    ..Other investigations are required in order to obtain relevant instruments for other domains, such as structural severity...
  93. ncbi Reliability of ultrasonography to detect synovitis in rheumatoid arthritis: a systematic literature review of 35 studies (1,415 patients)
    Peter P Cheung
    Paris Descartes University, Cochin Hospital, Paris, France
    Arthritis Care Res (Hoboken) 62:323-34. 2010
    ..US is a sensitive method for synovitis detection. However, reliability is still a key concern...
  94. ncbi Outcome measures for clinical trials of disease modifying osteoarthritis drugs in patients with hip osteoarthritis
    Maxime Dougados
    Service de Rhumatologie, , 27 Rue du Faubourg St-Jacques, Paris 75014, France
    J Rheumatol Suppl 70:66-9. 2004
  95. ncbi New concepts in the diagnosis and treatment of recent-onset polyarthritis
    Nouha Raissouni
    Rheumatology Department B, Cochin Teaching Hospital, 27 rue du Faubourg Saint Jacques, 75679 Paris Cedex 14, France
    Joint Bone Spine 72:119-23. 2005
    ..We used data from a comprehensive literature review to develop a diagnostic and therapeutic strategy for incipient undifferentiated inflammatory joint disease...
  96. ncbi The use of glucosamine therapy in osteoarthritis
    Djamila Zerkak
    Rheumatology B Department, , AP-HP Cochin Hospital, 27 rue du Faubourg Saint Jacques, Paris 75014, France
    Curr Rheumatol Rep 6:41-5. 2004
    ..An ongoing long-term clinical trial in the US will possibly permit to investigate the clinical relevance of these results and give appropriate recommendations...
  97. ncbi New tools for diagnosing spondyloarthropathy
    Samira Rostom
    UPRES EA 4058, département de rhumatologie B, Faculte de Medecine, Hopital Cochin, AP HP, Universite Paris Descartes, 27, rue du Faubourg St Jacques, 75014 Paris, France
    Joint Bone Spine 77:108-14. 2010
    ..The Assessment of SpondyloArthritis international Society (ASAS) has just issued new diagnostic criteria for AS that performed well in a large cohort of patients with recent-onset low back pain...
  98. ncbi Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study
    Desiree van der Heijde
    Department of Internal Medicine, Division of Rheumatology, University Hospital, Maastricht, The Netherlands
    Arthritis Rheum 52:1205-15. 2005
    ..To assess the efficacy, safety, and tolerability of etoricoxib, a cyclooxygenase 2 (COX-2) selective inhibitor, administered continuously over 52 weeks for the treatment of ankylosing spondylitis (AS)...
  99. ncbi Lefunomide in combination therapy
    Joachim R Kalden
    Department of Internal Medicine III, Universitaet Erlangen Nuremberg, Erlangen, Germany
    J Rheumatol Suppl 71:25-30. 2004
    ..The Expert Panel concluded that combination therapy with leflunomide has a place in the treatment of RA. Caution is advised, however, when using combination treatments and, therefore, the patient's safety should be carefully monitored...